Beyond GLP-1s: How device therapy could mitigate the obesity epidemic

It’s all about GLP-1s on this week’s episode. 

Pharma Editor Lecia Bushak speaks with Fractyl Health CEO Harith Rajagopalan about the company’s prospects in the weight loss space, the recent developments in the GLP-1 arms race and how this will impact marketing around these disease states in the future.

For the Trends segment, we’re continuing the GLP-1 focus with an update on how Eli Lilly is overtaking Novo Nordisk in the diabetes and obesity treatment market.

Check us out at: mmm-online.com

Follow us:

YouTube: @MMM-online

TikTok: @MMMnews

Instagram: @MMMnewsonline

Twitter/X: @MMMnews

LinkedIn: MM+M

To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Music: Opal 99 - Can't Go Out and Triple Scoop Music.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.